Overview

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of LEO 80185 gel with Dovobet® ointment in the treatment of psoriasis in Japanese subjects.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma
Collaborator:
CMIC Co, Ltd. Japan
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Calcipotriene
Calcitriol